Source link : https://www.newshealth.biz/health-news/wegovy-protects-against-deadly-covid-cases/
LONDON — The clinical benefits of semaglutide (Wegovy) went beyond expectations in the SELECT trial, given the reductions in non-cardiovascular and infectious disease deaths observed. Among people with overweight or obesity and pre-existing cardiovascular disease, the drop in all-cause deaths associated with weekly semaglutide injections versus placebo (4.3% vs 5.2%, HR 0.81, 95% CI 0.71-0.93) […]
Author : News Health
Publish date : 2024-08-30 08:33:00
Copyright for syndicated content belongs to the linked Source.